Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

medication abortion

medication abortion

2 results

Filter Results By

Filter Applied. Clear All

Latest Posts

September 13, 2024 Fact Sheet: Are Pro-Life State Laws Preventing Pregnant Women from Receiving Emergency Care? Fact Sheet: Are Pro-Life State Laws Preventing Pregnant Women from Receiving Emergency Care? September 10, 2024 New Study Reveals Increasing Severity and Frequency of Emergency Department Visits Following Use of Abortion Drugs New Study Reveals Increasing Severity and Frequency of Emergency Department Visits Following Use of Abortion Drugs September 4, 2024 Anti-abortion laws not to blame for OB-GYN shortages: Study Anti-abortion laws not to blame for OB-GYN shortages: Study
Reset All Filters
2 results
featured-image
medication abortion

Bicameral Congressional Letter Demands Transparency from FDA

Yesterday 75 members of Congress, led by Rep. Chris Smith of New Jersey and Sen. James Lankford of Oklahoma, sent a letter to the Commissioner of the Food and Drug Administration demanding answers to questions about the FDA’s surprise approval of relaxed protocols for the distribution of the abortion-inducing drug regimen known as Mifeprex.

Charles A. “Chuck” Donovan
April 26, 2016
Please login to bookmarkClose
medication abortion

Medication Abortion: FDA Guidelines and Personal Experience

Last week, the Food and Drug Administration (FDA) changed the regulations for RU-486, the “abortion pill,” allowing its use up to 70 days into pregnancy, three weeks past the previous guidelines. On the same day, Abby Johnson’s The Walls Are Talking: Former Abortion Clinic Workers Tell Their Stories, was officially released. One chapter in particular stood out as especially timely in regards to the news: “Medication Abortion.”

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image